Technology
Health
Pharmaceutical

Acer

$24.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.24 (-1.01%) Today
+$0.50 (2.13%) After Hours

Why Robinhood?

You can buy or sell Acer and other stocks, options, ETFs, and crypto commission-free!

About

Acer Therapeutics Inc. Common Stock (DE), also called Acer, is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Read More Its product pipeline includes Edsivo and ACER-001. The Edsivo is a type of celiprolol for Vascular Ehlers-Danlos syndrome. The ACER-001 is for the treatment of urea cycle disorders and Maple Syrup Urine diseases. The company was founded by Christopher Schelling in September 2017 and is headquartered in Newton, MA.

Employees
23
Headquarters
Newton, Massachusetts
Founded
2017
Market Cap
239.57M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
30.32K
High Today
$24.20
Low Today
$23.52
Open Price
$23.70
Volume
9.31K
52 Week High
$34.10
52 Week Low
$16.02

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
US
North America

News

Simply Wall StFeb 22

Loss-Making Acer Therapeutics Inc. (NASDAQ:ACER) Expected To Breakeven

Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Acer Therapeutics Inc.’s (NASDAQ:ACER): Acer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. The company’s loss has recently broadened since it announced a -US$14.2m loss in the full financial year, compared to the latest trailing-twelve-month loss of -US$17.0m, moving it further away from breakeven. Many inves...

47

Earnings

-$0.85
-$0.71
-$0.57
-$0.43
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.46 per share
Actual
-$0.85 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.